ArticleCurrent medical science2024

FPR1 Antagonist (BOC-MLF) Inhibits Amniotic Epithelial-mesenchymal Transition.

Xiao-Mei Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.